In summary, our study identified a pivotal role of GAS5, which was stabilized by NAT10-mediated ac4C modification, in modulating TME via MYBBP1A-p53/IRF1/type I interferon signaling axis in NSCLC. The gene discussed is IRF1; the disease is non-small cell lung carcinoma.